Johnson & Johnson’s MedTech unit has recently announced its plans to submit an application to the U.S. Food & Drug Administration (FDA) in the second half of 2024. The application aims to initiate clinical trials for their groundbreaking surgical robot, Ottava. This robotic system incorporates four robotic arms into a standard size surgical table and boasts the ability to reposition a patient seamlessly during a surgical procedure. The potential benefits of Ottava are immense and have the potential to revolutionize the field of robotic surgeries.
While Intuitive Surgical and its da Vinci surgical robot have dominated the market thus far, Johnson & Johnson’s entry into the robotic surgery space with Ottava is likely to shake things up. With its unique features and innovative design, Ottava has the potential to offer surgeons and patients a new level of precision and flexibility during surgical procedures.
The ability to reposition a patient without interrupting the surgical procedure is a significant advancement in the field of robotic surgeries. It eliminates the need for manual patient repositioning, reducing the risk of complications and surgical errors. This innovative feature can potentially improve patient outcomes and reduce the overall duration of surgical procedures.
FAQ:
Q: What is the Ottava robotic surgical system?
A: The Ottava robotic surgical system is a cutting-edge technology developed by Johnson & Johnson’s MedTech unit. It incorporates four robotic arms into a standard size surgical table and has the ability to reposition a patient without interrupting the surgical procedure.
Q: When will the clinical trials for Ottava begin?
A: Johnson & Johnson’s MedTech unit plans to submit an application to the FDA in the second half of 2024 to initiate clinical trials for the Ottava robotic surgical system.
Q: How does Ottava differ from other surgical robots in the market?
A: Ottava offers a unique feature of repositioning a patient without interrupting the surgical procedure, which sets it apart from other surgical robots in the market.
Sources:
– [Source 1](https://example.com)